Semler Scientific, Inc. (NASDAQ:SMLR) Shares Sold by Financial Management Professionals Inc.

Financial Management Professionals Inc. lessened its stake in Semler Scientific, Inc. (NASDAQ:SMLR) by 55.2% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,143 shares of the company’s stock after selling 1,410 shares during the quarter. Financial Management Professionals Inc.’s holdings in Semler Scientific were worth $33,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Advisory Services Network LLC acquired a new position in shares of Semler Scientific in the 4th quarter valued at $301,000. Allspring Global Investments Holdings LLC raised its stake in shares of Semler Scientific by 128.4% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 58,560 shares of the company’s stock valued at $2,594,000 after acquiring an additional 32,921 shares during the period. Exchange Traded Concepts LLC purchased a new position in shares of Semler Scientific in the 4th quarter valued at $383,000. Trexquant Investment LP purchased a new position in shares of Semler Scientific in the 3rd quarter valued at $345,000. Finally, Tower Research Capital LLC TRC raised its stake in shares of Semler Scientific by 250.5% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,103 shares of the company’s stock valued at $93,000 after acquiring an additional 1,503 shares during the period. Institutional investors and hedge funds own 49.37% of the company’s stock.

Semler Scientific Stock Performance

SMLR opened at $34.40 on Friday. The company has a 50-day moving average of $29.26 and a 200-day moving average of $36.22. The company has a market capitalization of $243.21 million, a P/E ratio of 12.33 and a beta of 0.96. Semler Scientific, Inc. has a 1-year low of $20.88 and a 1-year high of $53.38.

Semler Scientific (NASDAQ:SMLR) last released its earnings results on Tuesday, May 7th. The company reported $0.78 earnings per share for the quarter. The company had revenue of $15.90 million during the quarter. Semler Scientific had a net margin of 32.92% and a return on equity of 30.36%.

Analyst Ratings Changes

Several research firms recently issued reports on SMLR. Lake Street Capital raised shares of Semler Scientific to a “strong-buy” rating in a research note on Wednesday, May 8th. TheStreet raised shares of Semler Scientific from a “c+” rating to a “b-” rating in a research note on Friday, March 1st.

Semler Scientific Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.